HRP20110023T1 - Smanjenje prekomjerne težine ili pretilosti - Google Patents

Smanjenje prekomjerne težine ili pretilosti Download PDF

Info

Publication number
HRP20110023T1
HRP20110023T1 HR20110023T HRP20110023T HRP20110023T1 HR P20110023 T1 HRP20110023 T1 HR P20110023T1 HR 20110023 T HR20110023 T HR 20110023T HR P20110023 T HRP20110023 T HR P20110023T HR P20110023 T1 HRP20110023 T1 HR P20110023T1
Authority
HR
Croatia
Prior art keywords
reduction
overweight
obesity
use according
piperidino
Prior art date
Application number
HR20110023T
Other languages
English (en)
Inventor
Literati Nagy P�ter
Szilvassy Zolt�n
Tory K�lm�n
Vigh L�szl�
Takacs K�lm�n
Mandl J�zsef
S�megi Bal�zs
Bernath S�ndor
Kolonics Attila
Balogh G�bor
Egri J�nos
Original Assignee
N-Gene Research Laboratories Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N-Gene Research Laboratories Inc. filed Critical N-Gene Research Laboratories Inc.
Publication of HRP20110023T1 publication Critical patent/HRP20110023T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Abstract

Upotreba O-(3-piperidino-2-hidroksi-1-propil)-nikotinskog amidoksima ili njegove farmaceutski prihvatljive kisele adicijske soli naznačena time da je za pripremu farmaceutskog pripravka za prevenciju nenormalnog dobivanja na tjelesnoj težini ili za smanjenje prekomjerne težine ili pretilosti. Patent sadrži još 3 patentna zahtjeva.

Claims (4)

1. Upotreba O-(3-piperidino-2-hidroksi-1-propil)-nikotinskog amidoksima ili njegove farmaceutski prihvatljive kisele adicijske soli naznačena time da je za pripremu farmaceutskog pripravka za prevenciju nenormalnog dobivanja na tjelesnoj težini ili za smanjenje prekomjerne težine ili pretilosti.
2. Upotreba prema zahtjevu 1 naznačena time da se primjenjuje O-(3-piperidino-2-hidroksi-1-propil)-nikotinski amidoksim dihidroklorid.
3. Upotreba prema zahtjevu 1 ili 2 naznačena time da se farmaceutski pripravak koristi za smanjenje indeksa tjelesne mase od 25-30 kg/m2.
4. Upotreba prema zahtjevu 1 ili 2 naznačena time da se farmaceutski pripravak koristi za smanjenje indeksa tjelesne mase iznad 30 kg/m2.
HR20110023T 2006-11-02 2011-01-13 Smanjenje prekomjerne težine ili pretilosti HRP20110023T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85611706P 2006-11-02 2006-11-02
US11/687,945 US7763601B2 (en) 2006-11-02 2007-03-19 Prevention and treatment of obesity
PCT/HU2007/000066 WO2008053256A1 (en) 2006-11-02 2007-07-23 Reduction of overweight or obesity

Publications (1)

Publication Number Publication Date
HRP20110023T1 true HRP20110023T1 (hr) 2011-04-30

Family

ID=38592002

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110023T HRP20110023T1 (hr) 2006-11-02 2011-01-13 Smanjenje prekomjerne težine ili pretilosti

Country Status (20)

Country Link
US (1) US7763601B2 (hr)
EP (1) EP2089031B1 (hr)
JP (1) JP2010509199A (hr)
KR (1) KR20090082442A (hr)
AT (1) ATE489090T1 (hr)
AU (1) AU2007315931A1 (hr)
BR (1) BRPI0717867A2 (hr)
CA (1) CA2668382A1 (hr)
DE (1) DE602007010819D1 (hr)
DK (1) DK2089031T3 (hr)
HK (1) HK1131737A1 (hr)
HR (1) HRP20110023T1 (hr)
IL (1) IL198296A (hr)
MX (1) MX2009004538A (hr)
NO (1) NO20092025L (hr)
PL (1) PL2089031T3 (hr)
PT (1) PT2089031E (hr)
RU (1) RU2443417C2 (hr)
SI (1) SI2089031T1 (hr)
WO (1) WO2008053256A1 (hr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2586433T3 (es) 2007-04-11 2016-10-14 Omeros Corporation Composiciones y métodos para la profilaxis y el tratamiento de adicciones
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US20090281143A1 (en) * 2007-12-10 2009-11-12 N-Gene Research Laboratories, Inc. Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity
HUP1100445A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition
HUP1100444A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4287220A (en) * 1980-02-19 1981-09-01 Frito-Lay, Inc. Hull containing compositions
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
US6884424B2 (en) * 1995-12-22 2005-04-26 N-Gene Research Laboratories Inc. Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
US6458371B1 (en) * 1995-12-22 2002-10-01 Medgene, Limited Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin
HUP9701080A3 (en) * 1997-06-23 1999-05-28 Gene Res Lab Inc New York N Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
AU5296799A (en) 1998-08-03 2000-02-28 N-Gene Kutato Kft. Pharmaceutical compositions against autoimmune diseases
UA65635C2 (uk) * 1998-09-03 2004-04-15 Н-Гене Кутато Кфт. НЕНАСИЧЕНІ ПОХІДНІ ГІДРОКСИМОВОЇ КИСЛОТИ, ЩО МАЮТЬ ВЛАСТИВОСТІ ІНГІБІТОРІВ NAD<sup>+</sup>-ADP-РИБОЗИЛТРАНСФЕРАЗИ
CA2452558C (en) 2001-07-17 2009-12-22 N-Gene Research Laboratories Inc. A synergistic pharmaceutical combination for the prevention or treatment of diabetes
HUP0401176A2 (en) 2004-06-14 2007-09-28 N Gene Res Lab Inc Pharmaceutical composition having prpkinetic effect
HUP0401177A2 (en) 2004-06-14 2007-09-28 N Gene Res Lab Inc Pharmaceutical composition for increasing the mitochondrial genesis
HUP0500145A2 (en) 2005-01-28 2006-11-28 Gene Res Lab N Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases
JP2010502731A (ja) 2006-09-05 2010-01-28 バイパー サイエンシズ，インコーポレイティド Ｐａｒｐ阻害剤による脂肪酸合成の阻害、及びその治療方法

Also Published As

Publication number Publication date
BRPI0717867A2 (pt) 2013-10-29
PT2089031E (pt) 2011-02-24
IL198296A0 (en) 2010-02-17
CA2668382A1 (en) 2008-05-08
SI2089031T1 (sl) 2011-04-29
AU2007315931A1 (en) 2008-05-08
RU2009119567A (ru) 2010-12-10
US20080108673A1 (en) 2008-05-08
RU2443417C2 (ru) 2012-02-27
WO2008053256A1 (en) 2008-05-08
DK2089031T3 (da) 2011-02-14
US7763601B2 (en) 2010-07-27
JP2010509199A (ja) 2010-03-25
MX2009004538A (es) 2009-05-22
HK1131737A1 (en) 2010-02-05
PL2089031T3 (pl) 2011-05-31
ATE489090T1 (de) 2010-12-15
KR20090082442A (ko) 2009-07-30
EP2089031A1 (en) 2009-08-19
NO20092025L (no) 2009-06-02
EP2089031B1 (en) 2010-11-24
IL198296A (en) 2011-09-27
DE602007010819D1 (de) 2011-01-05

Similar Documents

Publication Publication Date Title
HRP20110023T1 (hr) Smanjenje prekomjerne težine ili pretilosti
MX2009011089A (es) Derivados de quinolina-carboxamida en calidad de antagonistas de p2y12.
TNSN08173A1 (en) Dispersible tablets comprising deferasirox
WO2009080227A3 (en) Pyrazole-carboxamide derivatives as p2y12 antagonists
TN2012000246A1 (en) Pharmaceutical compositions comprising sigma receptor ligands
TW200716121A (en) Acetylenyl-pyrazolo-pyrimidine derivatives as mGluR2 antagonists
MY150661A (en) Pyridin-3-yl derivatives as immunomodulating agents
MXPA05008368A (es) 1,2,4-triazinas inhibidoras del virus de inmunodeficiencia humana.
MX2010006799A (es) Benzofuropirimidinonas como inhibidores de la proteina cinasa.
TW200736232A (en) Pyrimidine derivatives
NO20085121L (no) Benzimidazolderivater, deres fremstillingsmate, deres anvendelse som FXR-agonister og farmasoytiske blandinger inneholdende samme
WO2006082523A3 (en) Pharmaceutical sustained release composition of metformin
TW200626593A (en) Novel compounds
WO2010142766A3 (en) Pyrimidine derivatives as zap-70 inhibitors
AR083150A1 (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona
WO2005123049A3 (en) A pharmaceutical composition for increasing the mitochondrial genesis
TW200718695A (en) Novel piperidine carboxylic acid amide derivatives
MX2009003169A (es) Derivados de sulfonamida.
MX2008016358A (es) Derivados de tiazolil-urea como inhibidores de cinasa de fosfatidil-inositol-3.
MX2009007429A (es) Compuestos de piridina y su uso como antagonistas de p2y12.
WO2009041786A3 (en) Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper longum for the prevention and treatment of inflammatory disease
WO2009049648A3 (en) Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof
GB0401513D0 (en) Compositions
TW200640472A (en) Solid pharmaceutical composition comprising telithromycin
MX2013003551A (es) Formas en estado solido de un potente inhibidor del vch.